EUVIMEDEUVIMED entdecken
Fallbericht

Transfer of Mexiletine into Breast Milk: A Case Report

Anaëlle Monfort iD, Caroline Morin, Martin Jutras, Stéphane Charest, Grégoire Leclair, Ema Ferreira

Breastfeeding Medicine · 01.06.2023 · 18 (6) · 489-493

DOI: 10.1089/bfm.2023.0042 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Breastfeeding Medicine, online erschienen am 15.06.2023. Verfasst von Anaëlle Monfort und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculté de Pharmacie, Université de Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Milk, Human, Breast Feeding. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: CIHR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mexiletine is a class 1B antiarrhythmic agent, used to treat ventricular arrhythmias, and noncardiac-related problems such as myotonia. Limited safety data are available on the transfer of this drug into breast milk. Case Report: We report the case of a woman diagnosed with myotonia congenita who breastfed two children after two consecutive pregnancies. During the breastfeeding of the first and the second infant, she collected, respectively, five and seven samples at 0, 2, 4, 6, and 8 hours and 0, 1, 2, 3, 4, 6, and 8 hours after taking 200 mg of mexiletine thrice daily for seven doses. One week after the collection, samples were analyzed with a validated liquid chromatography tandem mass spectrometry method. No side effect was observed in either child according to the mother.

Results

Using the mean milk concentrations, it is estimated that an exclusively breastfed infant would receive a maximum of 5.14% of the initial pediatric mexiletine dosage. We calculated a maximum of 2.67% for the first infant in our case, considering a nonexclusive breastfeeding. Maximal concentrations were observed 1–2 hours after the dose of mexiletine. Results seem to be in accordance with the two cases previously published.

Conclusions

Mexiletine transfers into breast milk in low levels. However, results are obtained from only one woman. Therefore, caution should be used when mexiletine is prescribed to breastfeeding women. More cases are needed to evaluate the interindividual variability and to guide women regarding breastfeeding with mexiletine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Milk, HumanBreast FeedingInfantPregnancyFemaleChildHumansMexiletineMothers

Stichwörter der Autor:innen

breast milkdrug exposuremexiletinepharmacokinetics

Substanzen

Mexiletine

Autor:innen und Institutionen

  • Faculté de Pharmacie, Université de Montréal, Montreal, Quebec, Canada.
  • Department of Pharmacy, CHU Sainte-Justine, Montreal, Quebec, Canada.
  • Department of Neurology, CIUSSS Mauricie et Centre du Québec, Trois-Rivières, Quebec, Canada.

ORCID-Profile: Anaëlle Monfort

Förderung

  • CIHR

Zitieren

APA

Monfort, A., Morin, C., Jutras, M., Charest, S., Leclair, G., & Ferreira, E. (2023). Transfer of Mexiletine into Breast Milk: A Case Report. Breastfeeding Medicine, 18(6), 489-493. https://doi.org/10.1089/bfm.2023.0042

Vancouver

Monfort A, Morin C, Jutras M, Charest S, Leclair G, Ferreira E. Transfer of Mexiletine into Breast Milk: A Case Report. Breastfeeding Medicine. 2023;18(6):489-493. doi:10.1089/bfm.2023.0042

BibTeX
@article{Monfort2023,
  author = {Monfort, Anaëlle and Morin, Caroline and Jutras, Martin and Charest, Stéphane and Leclair, Grégoire and Ferreira, Ema},
  title = {Transfer of Mexiletine into Breast Milk: A Case Report},
  journal = {Breastfeeding Medicine},
  year = {2023},
  volume = {18},
  number = {6},
  pages = {489--493},
  doi = {10.1089/bfm.2023.0042}
}
Kostenlos starten →